Quick Facts at a Glance
- Recall Date
- December 18, 2025
- Hazard Level
- HIGH
- Brand
- Imprimis NJOF
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- Imprimis NJOF
- Product type
- Intraocular Injection
- Model numbers
- 25MAY051, 25AUG003
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
December 18, 2025
Reported by FDA DRUG
January 14, 2026
RecallRadar source check
January 21, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Presence of particulate matter - Glass like particles.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Imprimis NJOF, LLC or your healthcare provider for guidance. Notification method: Letter
About This Product
Dexamethasone Moxifloxacin is an intraocular injection used primarily in eye surgeries or treatments to prevent infection and reduce inflammation. Consumers typically purchase this product through healthcare providers for specific medical conditions.
Why This Is Dangerous
The presence of glass-like particles can lead to serious complications if injected into the eye, potentially causing injury to the eye or surrounding tissues. This hazard is significant due to the sensitive nature of intraocular applications.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers face a significant safety risk if they have this product. Immediate action is necessary to prevent potential health complications.
Practical Guidance
How to identify if yours is affected
- Check the lot numbers on your product: 25MAY051 and 25AUG003.
- Verify the expiration dates: June 26, 2026, and August 7, 2026.
- If you have these lots, stop using the product immediately.
Where to find product info
Lot numbers and expiration dates can typically be found on the packaging or the syringe label.
What timeline to expect
Expect a refund processing timeline of approximately 4-6 weeks after returning the product.
If the manufacturer is unresponsive
- Document all correspondence with the company.
- Reach out again via a different communication method (phone or email).
- Consider filing a complaint with the FDA if no response is received.
How to prevent similar issues
- Always check for recalls on medications before use.
- Consult healthcare providers for safe alternative options.
- Verify lot numbers and expiration dates regularly.
Documentation advice
Keep records of your purchase, including receipts and any correspondence regarding the recall.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
The recalled product is Dexamethasone Moxifloxacin, available in 1 mg/mL and 5 mg/mL concentrations, packaged in 1 mL pre-filled syringes. The lot numbers affected include 25MAY051 and 25AUG003, with expiration dates of June 26, 2026, and August 7, 2026, respectively.
Key Facts
- Presence of glass-like particles
- Stop using immediately
- Contact healthcare provider for guidance
- Class II recall
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
